Literature DB >> 3484423

Acute bacterial sinusitis. Minocycline vs amoxicillin.

K F Mattucci, W J Levin, M A Habib.   

Abstract

The efficacy and safety of minocycline were compared with that of amoxicillin in the treatment of 58 patients with acute bacterial sinusitis. The most frequently isolated pathogens were streptococci, staphylococci, and Haemophilus influenzae. After therapy for a mean time of 11 days, clinical cure or improvement and bacterial eradication were evident in 100% of the patients treated with minocycline and in 95% of the patients treated with amoxicillin. Roentgenographic results indicated clearing or improvement in 91% of the minocycline recipients and in 70% of those who received amoxicillin. These differences between treatments were not statistically significant. A low incidence of generally mild adverse clinical experiences occurred in both treatment groups. Thus, minocycline and amoxicillin were equally safe and effective in the treatment of these patients with acute bacterial sinusitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484423     DOI: 10.1001/archotol.1986.03780010075014

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Economic evaluation of antibacterials in the treatment of acute sinusitis.

Authors:  C Laurier; J Lachaine; M Ducharme
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

2.  Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis.

Authors:  S D de Ferranti; J P Ioannidis; J Lau; W V Anninger; M Barza
Journal:  BMJ       Date:  1998-09-05

3.  Amoxicillin concentrations in nasal secretions of patients with acute uncomplicated sinusitis and in paranasal sinus mucosa of patients with chronic sinusitis.

Authors:  G Kment; A Georgopoulos; W Ridl; J Mühlbacher
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Acute sinusitis: guide to selection of antibacterial therapy.

Authors:  Morten Lindbaek
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.